Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
about
Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@ast
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@en
type
label
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@ast
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@en
prefLabel
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@ast
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@en
P50
P1476
Co-delivery of peptide-modifie ...... uscle-invasive bladder cancer.
@en
P2093
Ratha Mahendran
P304
P356
10.1016/J.EJPS.2016.01.013
P407
P577
2016-01-15T00:00:00Z